| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/28/2008 | WO2008024963A1 Benzene, pyridine, and pyridazine derivatives |
| 02/28/2008 | WO2008024492A2 Indolinone phenylaminopropanol derivatives and process for the preparation thereof |
| 02/28/2008 | WO2008024439A2 4-aminoquinazoline derivatives and methods of use thereof |
| 02/28/2008 | WO2008023828A1 Chromene compound |
| 02/28/2008 | WO2008023720A1 Urea compound or salt thereof |
| 02/28/2008 | WO2008023239A1 Pyrimidone compounds as gsk-3 inhibitors |
| 02/28/2008 | WO2008023235A1 Pyrazole derivatives as anti-platelet and anti-thrombotic agents |
| 02/28/2008 | WO2008023159A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 02/28/2008 | WO2008022979A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 02/28/2008 | WO2008022725A1 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral disorders |
| 02/28/2008 | WO2007139967A3 Triazole compounds that modulate hsp90 activity |
| 02/28/2008 | WO2007120730A3 Fused ring thrombin receptor antagonists |
| 02/28/2008 | WO2007025043A3 Seven-membered ring nucleosides |
| 02/28/2008 | US20080051580 Process to Prepare Camptothecin Derivatives and Novel Intermediate and Compounds Thereof |
| 02/28/2008 | US20080051575 capable of switching between the two states in response to at least actinic radiation; thermally reversible |
| 02/28/2008 | US20080051422 4-Aminoquinazoline derivatives and methods of use thereof |
| 02/28/2008 | US20080051415 Novel piperazines, pharmaceutical compositions and methods of use thereof |
| 02/28/2008 | US20080051388 Novel Compounds That Inhibit Factor Xa Activity |
| 02/28/2008 | CA2665804A1 Urea compound or salt thereof |
| 02/28/2008 | CA2660084A1 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral diseases |
| 02/28/2008 | CA2657183A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 02/27/2008 | EP1892239A1 Inhibitors of cytosolic phospholipase A2 |
| 02/27/2008 | EP1891951A1 Viral polymerase inhibitors |
| 02/27/2008 | EP1891950A1 Viral polymerase inhibitors |
| 02/27/2008 | EP1891065A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders |
| 02/27/2008 | EP1891058A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 02/27/2008 | EP1891048A1 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders |
| 02/27/2008 | EP1891047A2 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents |
| 02/27/2008 | EP1891040A1 Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators and related methods of synthesis |
| 02/27/2008 | EP1891038A2 Substituted n-arylpyrrolidines as selective androgen receptor modulators |
| 02/27/2008 | EP1891034A2 Processes for preparing darifenacin hydrobromide |
| 02/27/2008 | EP1891017A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 02/27/2008 | EP1891011A1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5 |
| 02/27/2008 | EP1890703A2 Pyrimidine compounds |
| 02/27/2008 | EP1890672A1 Use of chromone derivatives |
| 02/27/2008 | EP1610786B9 4-(4-(heterocyclylalkoxy phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's |
| 02/27/2008 | EP1483266B1 Spiro compounds with npy antagonistic activity |
| 02/27/2008 | EP1471065B1 Novel 1,2,4-triazole compound |
| 02/27/2008 | EP1399423B9 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds |
| 02/27/2008 | EP1395564B1 Quinoline derivatives as ligands for the neuropeptide y receptor |
| 02/27/2008 | EP1268470B1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | EP1246806B1 Arly- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 02/27/2008 | CN101133038A HIV inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines |
| 02/27/2008 | CN101133036A Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS) |
| 02/27/2008 | CN101133033A 5-aminopyrazole derivatives as pesticidal compounds |
| 02/27/2008 | CN101133010A Process and intermediate compounds useful in the preparation of statins |
| 02/27/2008 | CN101130516A Method for purifying and enriching benzene acryloyl 5- hydroxytryptamine derivant in safflower seed |
| 02/27/2008 | CN101130515A Substituted-1H- indoles compound, method for preparing the same, application and pharmaceutical composition of the same |
| 02/27/2008 | CN101130514A Intermediate for the preparation of epimino |
| 02/27/2008 | CN100371329C Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 02/27/2008 | CN100371322C 2-pyrrolidone derivatives as prostanoid agonists |
| 02/27/2008 | CA2660758A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 02/26/2008 | US7335799 administering to a patient a hydroxy compound to treat aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, septicemia and syndrome X |
| 02/26/2008 | US7335775 Effector conjugates, process for their production and their pharmaceutical use |
| 02/26/2008 | US7335774 Quinolinone derivatives |
| 02/26/2008 | US7335689 for example, 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid, 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol, 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; treatment of Alzheimer's Disease, metabolic syndrome disorder, cancer, cardiovascular disease, diabetic nephropathy |
| 02/26/2008 | US7335682 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye |
| 02/26/2008 | US7335680 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid |
| 02/26/2008 | US7335679 Wortmannin analogs and methods of using same |
| 02/26/2008 | US7335678 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor |
| 02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
| 02/26/2008 | US7335670 Specific inhibitors of the glycine transporters glyt1 and/or glyt2; psychoses, contracture, pain, Parkinson's disease, epilepsy, and sleep apnea |
| 02/26/2008 | US7335666 That inhibit serotonin reuptake and are antagonists of the 5HT1A receptor; 2-[3-(6-Fluoro-indol-1-ylmethyl)-azetidin-1-ylmethyl]-8-methyl-2,3-dihydro-[1,4]dioxino[2,3-f]quinoline for example |
| 02/26/2008 | US7335665 Spirocyclic piperidines as MCH1 antagonists and uses thereof |
| 02/26/2008 | US7335662 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 4-(4-pyrimid-2-ylaminosulfonyl-1,4-phenylene-aminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole |
| 02/26/2008 | US7335660 Using a 2-benzopyran-6-carboxamide compound |
| 02/26/2008 | US7335656 Medical devices employing triazine compounds and compositions thereof |
| 02/26/2008 | US7335649 3-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2-hydroxy-3'-(tetrazol-5-yl)biphenyl for treatment of thrombocytopenia; colony stimulating factors |
| 02/21/2008 | WO2008021891A2 Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
| 02/21/2008 | WO2008020607A1 Phthalide derivative and salt thereof |
| 02/21/2008 | WO2008020306A2 Isoindole derivatives |
| 02/21/2008 | WO2008020203A1 Pyridinylquinaz0linamine derivatives and their use as b-raf inhibitors |
| 02/21/2008 | WO2007149512A3 Peptide epoxyketones for pr0teas0me inhibition |
| 02/21/2008 | WO2007101213A3 Novel 2-oxo-1,2,3,4-tetrahydropyrimidines, bicyclic pyrimidine diones and imidazolidine-2,4-diones useful as inducible nitric oxide synthase inhibitors |
| 02/21/2008 | US20080045714 Method for Producing Cyclic Diamine Derivative |
| 02/21/2008 | US20080045704 Photochromic compounds |
| 02/21/2008 | US20080045581 Ppar active compounds |
| 02/21/2008 | US20080045569 Cyclic Amine Compound and Pest Control Agent |
| 02/21/2008 | US20080045560 Pyrrolidine and related derivatives useful as PR modulators |
| 02/21/2008 | US20080045541 Dihydropyridinone Derivatives |
| 02/21/2008 | US20080045540 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 02/21/2008 | US20080045505 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators |
| 02/21/2008 | US20080045493 such as Parkinson's disease, schizophrenia, cognitive disorders, depression, anxiety, drug addiction, eating disorders and urogenital disorders; 4-(2,2-Difluoro-cyclopropyl)-N-[4-(1-propyl-piperidin-3-yl)-phenyl]-benzenesulfonamide |
| 02/21/2008 | US20080044881 Advanced Indolinone Based Protein Kinase Inhibitors |
| 02/21/2008 | CA2660318A1 Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activit y and use thereof |
| 02/21/2008 | CA2659299A1 Azetidine compounds |
| 02/21/2008 | CA2658960A1 Phenyl, pyridine and quinoline derivatives |
| 02/20/2008 | EP1889843A1 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds |
| 02/20/2008 | EP1889839A1 Bicyclic compound, production and use as HIV inhibitors |
| 02/20/2008 | EP1889838A1 Thrombopoietin mimetics |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1888569A1 Substituted piperidines as renin inhibitors |
| 02/20/2008 | EP1888567A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors |
| 02/20/2008 | EP1888564A2 Benzofuran compounds |
| 02/20/2008 | EP1888559A2 Piperazine-piperidine antagonists and agonists of the 5-ht1a receptor |
| 02/20/2008 | EP1888532A1 Heteroaroyl-substituted serine amides |
| 02/20/2008 | EP1888530A2 Quinoline derivatives as neurokinin receptor antagonists |
| 02/20/2008 | EP1888518A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 02/20/2008 | EP1888517A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |